Department of Pharmacy, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Shmunis School of Biomedical and Cancer Research, The George S. Wise Faculty of Life Sciences, Tel Aviv Universitygrid.12136.37, Tel Aviv, Israel.
mBio. 2021 Aug 31;12(4):e0227221. doi: 10.1128/mBio.02272-21.
How cells exposed to one stress are later able to better survive other types of stress is not well understood. In eukaryotic organisms, physiological and pathological stresses can disturb endoplasmic reticulum (ER) function, resulting in "ER stress." Here, we found that exposure to tunicamycin, an inducer of ER stress, resulted in the acquisition of a specific aneuploidy, chromosome 2 trisomy (Chr2x3), in Candida albicans. Importantly, the resulting aneuploidy also conferred cross-tolerance to caspofungin, a first-line echinocandin antifungal, as well as to hydroxyurea, a common chemotherapeutic agent. Exposure to a range of tunicamycin concentrations induced similar ER stress responses. Extra copies of one Chr2 gene, , affected both tunicamycin and caspofungin tolerance, while at least 3 genes on chromosome 2 (, , and ) affected only tunicamycin and not caspofungin responses. Other Chr2 genes ( and ) affected hydroxyurea tolerance but neither tunicamycin nor caspofungin tolerance. Deletion of components of the protein kinase C (PKC) or calcineurin pathways affected tolerance to both tunicamycin and caspofungin, supporting the idea that the ER stress response and echinocandin tolerance are regulated by overlapping stress response pathways. Thus, antifungal drug tolerance can arise rapidly via ER stress-induced aneuploidy. Candida albicans is a prevalent human fungal commensal and also a pathogen that causes life-threatening systemic infections. Treatment failures are frequent because few therapeutic antifungal drug classes are available and because drug resistance and tolerance limit drug efficacy. We found that C. albicans rapidly overcomes the cellular stress induced by the drug tunicamycin by duplicating chromosome 2. Also, chromosome 2 duplication confers tolerance not only to tunicamycin but also to the following two unrelated drugs: caspofungin, an antifungal drug, and hydroxyurea, a chemotherapeutic. Cross tolerance to the three drugs involves different sets of genes, although some genetic pathways affect the tolerance to two of these three drugs. This work highlights a serious concern, namely, that changes in whole chromosome copy number can occur in response to one type of stress, and yet, they may facilitate the emergence of tolerance to multiple drugs, including the few antifungal drug classes available to treat infections.
细胞如何在暴露于一种应激后更好地存活其他类型的应激尚不清楚。在真核生物中,生理和病理应激会干扰内质网(ER)的功能,导致“ER 应激”。在这里,我们发现,暴露于衣霉素,一种内质网应激诱导剂,导致念珠菌获得特定的非整倍体,2 号染色体三体(Chr2x3)。重要的是,由此产生的非整倍体也赋予了交叉耐 caspofungin,一种一线棘白菌素抗真菌药物,以及羟基脲,一种常见的化疗药物。暴露于一系列衣霉素浓度诱导相似的 ER 应激反应。一个 Chr2 基因的额外拷贝, ,影响衣霉素和 caspofungin 的耐受性,而 2 号染色体上的至少 3 个基因( , ,和 )仅影响衣霉素而不影响 caspofungin 反应。其他 Chr2 基因( 和 )影响羟基脲的耐受性,但既不影响衣霉素也不影响 caspofungin 的耐受性。蛋白激酶 C(PKC)或钙调神经磷酸酶途径的成分缺失影响对衣霉素和 caspofungin 的耐受性,支持 ER 应激反应和棘白菌素耐受性受重叠应激反应途径调节的观点。因此,抗真菌药物的耐受性可以通过 ER 应激诱导的非整倍体迅速产生。白色念珠菌是一种常见的人类真菌共生体,也是一种导致危及生命的全身性感染的病原体。治疗失败很常见,因为可用的治疗性抗真菌药物种类很少,而且药物耐药性和耐受性限制了药物的疗效。我们发现,白色念珠菌通过复制染色体 2 迅速克服了药物衣霉素诱导的细胞应激。此外,染色体 2 复制不仅赋予了对衣霉素的耐受性,而且赋予了以下两种不相关的药物的耐受性:棘白菌素,一种抗真菌药物,和羟基脲,一种化疗药物。对这三种药物的交叉耐受涉及不同的基因集,尽管一些遗传途径影响对这三种药物中的两种的耐受性。这项工作强调了一个严重的问题,即整个染色体拷贝数的变化可能会对一种应激做出反应,但它们可能会促进对多种药物的耐受性的出现,包括治疗感染的少数几种抗真菌药物类别。